These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10088614)

  • 1. Measure once or twice -- does it really matter?
    Hilsenbeck SG; Von Hoff DD
    J Natl Cancer Inst; 1999 Mar; 91(6):494-5. PubMed ID: 10088614
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Measure once or twice--does it really matter?
    James K; Eisenhauer E; Therasse P
    J Natl Cancer Inst; 1999 Oct; 91(20):1780-1. PubMed ID: 10528032
    [No Abstract]   [Full Text] [Related]  

  • 3. Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?
    Aich A; Gupta P; Gupta K
    Int Anesthesiol Clin; 2016; 54(4):e1-e16. PubMed ID: 27602710
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal lesion number for evaluation of tumor response in response evaluation criteria in solid tumors.
    Rosen MA; Sullivan D
    J Clin Oncol; 2010 Apr; 28(10):e159-60; author reply e161. PubMed ID: 20159810
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor Response Evaluation Criteria: Standardization Ensures Success.
    Zaman MU; Fatima N; Sajid M
    J Coll Physicians Surg Pak; 2017 Jul; 27(7):389-391. PubMed ID: 28818157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activity, objective response, and WHO and RECIST (Response Evaluation Criteria In Solid Tumor) evaluation criteria].
    De Angelis V
    Suppl Tumori; 2004; 3(4):S7-9. PubMed ID: 15206198
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
    Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
    Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying sensitivity analyses to overall survival in cancer clinical trials.
    Wolff SN
    J Clin Oncol; 2010 Jul; 28(19):e323; author reply e324. PubMed ID: 20516448
    [No Abstract]   [Full Text] [Related]  

  • 9. The importance of the differentiating syndromes for the efficacy assessment of Chinese medicine in the treatment of cancer.
    Wu WY
    Chin J Integr Med; 2010 Feb; 16(1):6-8. PubMed ID: 20131027
    [No Abstract]   [Full Text] [Related]  

  • 10. Progression of an untreated pseudotumor.
    Iqbal M; Comp PC; Wu DH
    Haemophilia; 2017 Sep; 23(5):e464-e466. PubMed ID: 28664672
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging concepts in tumor progression and therapy.
    Classon M; Settleman J
    Semin Cancer Biol; 2000 Dec; 10(6):393-7. PubMed ID: 11170861
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer-related inflammation and treatment effectiveness.
    Diakos CI; Charles KA; McMillan DC; Clarke SJ
    Lancet Oncol; 2014 Oct; 15(11):e493-503. PubMed ID: 25281468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic disease response to treatment: how many lesions to measure?
    Prassopoulos P; Mantatzis M
    J Clin Oncol; 2010 Feb; 28(5):e81; author reply 82. PubMed ID: 19841318
    [No Abstract]   [Full Text] [Related]  

  • 14. PET scan in the therapeutic strategy.
    Haioun C; Itti E; Rahmouni A; Meignan M; Reyes F
    Hematol J; 2004; 5 Suppl 3():S149-53. PubMed ID: 15190298
    [No Abstract]   [Full Text] [Related]  

  • 15. Lifestyle during and after cancer treatment.
    Thomas R; Davies N
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):616-27. PubMed ID: 17689058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-Life Care Intensity Among Adolescent and Young Adult Patients With Cancer in Kaiser Permanente Southern California.
    Mack JW; Chen LH; Cannavale K; Sattayapiwat O; Cooper RM; Chao CR
    JAMA Oncol; 2015 Aug; 1(5):592-600. PubMed ID: 26181778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once or twice-daily, algorithm-based intravenous cephazolin for home-based cellulitis treatment.
    Garrett T; Harbort Y; Trebble M; Docherty T
    Emerg Med Australas; 2012 Aug; 24(4):383-92. PubMed ID: 22862755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RECIST 1.1-Update and clarification: From the RECIST committee.
    Schwartz LH; Litière S; de Vries E; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; Seymour L
    Eur J Cancer; 2016 Jul; 62():132-7. PubMed ID: 27189322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-progressing to an unmet need.
    Fojo T
    Semin Oncol; 2017 Feb; 44(1):1-2. PubMed ID: 28395757
    [No Abstract]   [Full Text] [Related]  

  • 20. Preface.
    Pruitt K
    Prog Mol Biol Transl Sci; 2016; 144():xiii. PubMed ID: 27865470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.